RSV newborn immunization coverage expanding in Sask.

REGINA — The Respiratory Syncytial Virus (RSV) Infant Immunization program in Saskatchewan is expanding to include all babies born between Oct. 1 and March 31. Previously the program was only available to high-risk newborns in the province.

The antibody treatment is designed to protect newborn babies and infants who are born during or entering their first RSV season, which occurs during the late fall and winter months. Children who are considered high risk of severe RSV disease will continue to be covered under the program for their first two RSV seasons.

The RSV program is a single-dose injection that provides protection through pre-made RSV antibodies. The antibody injection is safe with minimal side effects and it shows to be highly effective in reducing infant hospitalization rates. The injection is currently only offered in hospital at the time of birth. For more information, patients and families are encouraged to discuss RSV immunization with their primary health care provider, prenatal care team and in-hospital health care staff.

RSV is a common virus that spreads quickly and easily, especially during colder months. The goal of the provincial immunization program is to provide protection when infants and children are most at risk of exposure and ensure they are protected for the duration of the RSV season.

RSV infects the lungs causing pneumonia or bronchiolitis and can lead to emergency room visits and hospitalization. RSV bronchiolitis is one of the most common reasons for hospitalization of infants worldwide and has a significant impact on caregivers and families. Premature babies and infants with chronic heart or lung disease are at the highest risk of developing severe infections and death.

Learn more about Saskatchewan’s RSV Infant Immunization program here.